QuatRx Pharmaceuticals Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
51
- Latest Deal Type
-
M&A
QuatRx Pharmaceuticals General Information
Description
Developer of compounds in the areas of endocrine, metabolic and cardiovascular therapeutics. The company's products are used for the treatment for vaginal atrophy, a common problem associated with estrogen deficiency in post-menopausal women as well as for the treatment of testosterone deficiency and other conditions in men.
Contact Information
Website
www.quatrx.comCorporate Office
- 777 East Eisenhower Parkway
- Suite 100
- Ann Arbor, MI 48108
- United States
Corporate Office
- 777 East Eisenhower Parkway
- Suite 100
- Ann Arbor, MI 48108
- United States
QuatRx Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 17. Merger/Acquisition | 10-Mar-2017 | Completed | Generating Revenue | |||
| 16. Later Stage VC | Completed | Generating Revenue | ||||
| 15. Secondary Transaction - Stock Distribution | 27-Nov-2013 | Completed | Generating Revenue | |||
| 14. Debt - General | 08-Jul-2013 | Completed | Generating Revenue | |||
| 13. Later Stage VC | 24-Apr-2009 | Completed | Generating Revenue | |||
| 12. Debt - General | 22-Dec-2008 | Completed | Generating Revenue | |||
| 11. Debt - General | 21-Nov-2008 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series E) | 22-May-2007 | Completed | Generating Revenue | |||
| 9. IPO | 07-Jul-2006 | $72M | Cancelled | Generating Revenue | ||
| 8. Debt - General | 31-Mar-2006 | $6M | $78.9M | Completed | Startup |
QuatRx Pharmaceuticals Comparisons
Industry
Financing
Details
QuatRx Pharmaceuticals Competitors (11)
One of QuatRx Pharmaceuticals’s 11 competitors is The Zambon Group, a Private Debt Financed company based in Bresso, Italy.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| The Zambon Group | Private Debt Financed | Bresso, Italy | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Gilead | Formerly VC-backed | Foster City, CA | ||||
| Astellas Pharma | Corporation | Tokyo, Japan | ||||
| United Therapeutics | Formerly VC-backed | Silver Spring, MD |
QuatRx Pharmaceuticals Patents
QuatRx Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2009089093-A1 | Thyroid hormone receptor agonists | Inactive | 04-Jan-2008 | ||
| US-10500166-B2 | Methods for the treatment of erectile dysfunction using fispemifene | Inactive | 13-Jun-2007 | ||
| US-20080312239-A1 | Methods for the treatment of erectile dysfunction using fispemifene | Inactive | 13-Jun-2007 | ||
| US-20100261729-A1 | Methods for the treatment of erectile dysfunction using fispemifene | Inactive | 13-Jun-2007 | ||
| US-20130217696-A1 | Methods for the treatment of erectile dysfunction using fispemifene | Active | 13-Jun-2007 | A61K31/085 |
QuatRx Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
QuatRx Pharmaceuticals Former Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aboa Venture Management | PE/Buyout | Minority | ||
| BankInvest Group | Asset Manager | Minority | ||
| BioFund Ventures | Venture Capital | Minority | ||
| Frazier Healthcare Partners | PE/Buyout | Minority | ||
| H&B Capital Advisors | Venture Capital | Minority |
QuatRx Pharmaceuticals Acquisitions (1)
QuatRx Pharmaceuticals’s most recent deal was a Merger/Acquisition with Hormos Medical. The deal was made on 16-May-2005.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Hormos Medical | 16-May-2005 | Merger/Acquisition | Drug Discovery |
QuatRx Pharmaceuticals FAQs
-
When was QuatRx Pharmaceuticals founded?
QuatRx Pharmaceuticals was founded in 2000.
-
Where is QuatRx Pharmaceuticals headquartered?
QuatRx Pharmaceuticals is headquartered in Ann Arbor, MI.
-
What is the size of QuatRx Pharmaceuticals?
QuatRx Pharmaceuticals has 51 total employees.
-
What industry is QuatRx Pharmaceuticals in?
QuatRx Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is QuatRx Pharmaceuticals a private or public company?
QuatRx Pharmaceuticals is a Private company.
-
What is QuatRx Pharmaceuticals’s current revenue?
The current revenue for QuatRx Pharmaceuticals is .
-
How much funding has QuatRx Pharmaceuticals raised over time?
QuatRx Pharmaceuticals has raised $163M.
-
Who are QuatRx Pharmaceuticals’s investors?
Aboa Venture Management, BankInvest Group, BioFund Ventures, Frazier Healthcare Partners, and H&B Capital Advisors are 5 of 18 investors who have invested in QuatRx Pharmaceuticals.
-
Who are QuatRx Pharmaceuticals’s competitors?
The Zambon Group, Pfizer (Vienna), Gilead, Astellas Pharma, and United Therapeutics are some of the 11 competitors of QuatRx Pharmaceuticals.
-
When was QuatRx Pharmaceuticals acquired?
QuatRx Pharmaceuticals was acquired on 10-Mar-2017.
-
Who acquired QuatRx Pharmaceuticals?
QuatRx Pharmaceuticals was acquired by Shionogi.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
